Press release content from TS Newswire. The AP news staff was not involved in its creation.
Click to copy
New York, 10016 ( TS Newswire ) — 02 Oct 2020
Fat is the biggest enemy to good health at the present. According to a health report, nearly 35% of the worlds adult population is overweight and has a collection of fat in their body. It is an alarming statistic when it comes to the health and fitness status of the world. Today a lot of humans are suffering from the problems of heart and kidney failures and the major cause for them is the accumulated fat in their body. This fat tends to harm the body and make a person inactive. The major source of fat for a person is their diet. CLICK HERE TO ORDER ALPHA EVOLUTION KETO CANADA .
JACKSONVILLE, Fla., Sept. 22, 2020 /PRNewswire/ — The American Association of Clinical Endocrinologists (AACE), a professional community of health care providers specializing in endocrinology, diabetes and metabolic disorders, is hosting the first Innovation in Cardiometabolic Clinical Practice virtual conference from October 2-4, 2020. The conference will offer interactive learning sessions on translational medicine and clinical applications of evidence-based guidelines for physicians and health professionals across specialties who are caring for patients with cardiometabolic diseases. Registration for the conference is now open and free for all attendees.
The conference is co-provided by the National Kidney Foundation (NKF), American Association for the Study of Liver Diseases (AASLD), American Society of Preventive Cardiology (ASPC), Preventive Cardiovascular Nurses Association (PCNA) and Endocrine Nurses Society (ENS). The collaboration among these leading organizations in cardiometabolic disease will ensure that the conference integrates multidisciplinary perspectives and fosters increased coordination among a patient’s care team.
BEIJING and SUZHOU, China, Sept. 25, 2020 (GLOBE NEWSWIRE) — Genetron Holdings Limited (“Genetron Health”, Nasdaq: GTH), a leading precision oncology platform company in China that specializes in offering molecular profiling tests, early cancer screening products and companion diagnostics development, and its strategic partner CStone Pharmaceuticals (“CStone”, HKEX: 2616) today announced the launch of a multi-center clinical trial in China for the joint development of a companion diagnostic (CDx) test for avapritinib. This represents a key milestone in the companies’ collaboration. Avapritinib is a kinase inhibitor discovered by CStone’s partner Blueprint Medicines.
Genetron Health and CStone are jointly developing a CDx kit to detect the D842V mutation in the human platelet-derived growth factor receptor alpha (PDGFRA) gene using a polymerase chain reaction (PCR)-based method. The CDx test kit utilizes a real-time PCR fluorescent probe, combined with specific primers, Taqman probes, and highly specific Taq enzymes, to detect the mutation with
PHILADELPHIA, Sept. 21, 2020 /PRNewswire/ — Signant Health today introduced “eCOA Explained,” a new Master Class web series designed to elevate the understanding and skills of clinical operations professionals interested in electronic clinical outcome assessments (eCOA).
The educational and complimentary class launches with three courses and 16 on-demand lessons designed for all levels of eCOA experience, as taught by 13 clinical research science and technology experts. To enroll and start learning, visit www.ecoaexplained.com.
Lessons available now include:
Build Your eCOA Solution
eCOA 101: The Basics (Jill Platko, PhD)
How to Build an eDiary: What’s Involved (Brandy Morneau)
From Paper to ePRO Measures: Licensing, Migration and Translation (Alex Kalpadakis-Smith, PhD)
How to Make Translations Work for Everyone (Adina Tapalaga)
To BYOD or Not to BYOD? (Bill Byrom, PhD)
Complex Diaries: Best Practices and Considerations (Jill Platko, PhD)